MDACC Study No:2008-0133 ( NCT No: NCT00915005)
Title: A Bayesian randomized trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, with Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence
Principal Investigator:Zhongxing Liao
Treatment Agent:Carboplatin; Chemotherapy; Paclitaxel; Proton Therapy
Study Status:Closed
Study Description:Unavailable
Hide details for General InformationGeneral Information

Disease Group:Lung
Phase of Study:Phase II
Treatment Agents:Carboplatin
Proton Therapy
Treatment Location:Both at MDACC & outside MDACC at one or more Collaborating Sites or Institutions
Estimated Length of Stay in Houston:n/a
Supported By:2 PO1 CA021239-29A1
Return Visit:Once a week during the chemoradiation. Follow-up visit 4–8 weeks after
completion of the treatment, then every 3-4 months for 3 years, then every 6
months for to the next 2 years, and then annually thereafter.
Home Care:n/a

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Zhongxing Liao
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults